Working… Menu

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03797261
Recruitment Status : Suspended (Safety)
First Posted : January 9, 2019
Last Update Posted : December 17, 2020
Genentech, Inc.
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 2, 2022
Estimated Study Completion Date : September 2, 2022